Literature DB >> 23066723

The JR blood group system (ISBT 032): molecular characterization of three new null alleles.

Kim Hue-Roye1, Christine Lomas-Francis, Gail Coghlan, Teresa Zelinski, Marion E Reid.   

Abstract

BACKGROUND: Jr(a) (ISBT 901005) is a high-prevalence antigen unassigned to a blood group system. People lacking this antigen have been found in all populations studied but most commonly in Asians. Two recent reports established that ABCG2-null alleles encode the Jr(a-) phenotype and these studies provided the impetus to study other Jr(a-) individuals. STUDY DESIGN AND METHODS: Blood samples were part of our rare donor-patient collection. DNA was isolated and analyzed by standard techniques.
RESULTS: In samples from 13 Jr(a-) study subjects, we found six alleles with nonsense nucleotide changes, three (c.784T, c.1591T, and c.337T) were novel. Twelve of the samples were homozygous for nonsense single-nucleotide polymorphisms (SNPs): eight were c.376T, two were c.706T, one was c.784T, and one was c.1591T. Each of these alleles predicts a truncated ABCG2 product, Gln126Stop, Arg236Stop, Gly262Stop, and Gln531Stop, respectively. One study subject was heterozygous for two nonsense SNPs: c.337C/T (Arg113Stop) and c.736C/T (Arg246Stop).
CONCLUSIONS: Jr(a) is the sole antigen in the newly established JR blood group system (ISBT 032001). The previous ISBT designation (901005) is now obsolete. Since ABCG2null alleles define the Jr(a-) phenotype, an explanation for why no antithetical low-prevalence antigen to Jr(a) has been found, and also why anti-Jr(a) made by people with any of these JRnull alleles are mutually compatible has been determined. Based on our findings DNA-based genotyping can be developed to replace the serologic methods that are currently used to identify Jr(a-) blood donors.
© 2012 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23066723     DOI: 10.1111/j.1537-2995.2012.03930.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  2 in total

1.  Genomic coordinates and continental distribution of 120 blood group variants reported by the 1000 Genomes Project.

Authors:  Celina Montemayor-Garcia; Panagiota Karagianni; David A Stiles; Erika M Reese; Danielle A Smellie; Debrean A Loy; Kimberly Y Levy; Magdalene Nwokocha; Marina U Bueno; Jeffery L Miller; Harvey G Klein
Journal:  Transfusion       Date:  2018-10-12       Impact factor: 3.157

2.  International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Cancun report (2012).

Authors:  J R Storry; L Castilho; G Daniels; W A Flegel; G Garratty; M de Haas; C Hyland; C Lomas-Francis; J M Moulds; N Nogues; M L Olsson; J Poole; M E Reid; P Rouger; E van der Schoot; M Scott; Y Tani; L-C Yu; S Wendel; C Westhoff; V Yahalom; T Zelinski
Journal:  Vox Sang       Date:  2013-12-27       Impact factor: 2.144

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.